Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ01
- Pharmacological subgroupJ01D
- Chemical subgroupJ01DD
- Chemical substanceJ01DD14
Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 2 medicines
- Cedax400MG BASE · capsule · Burke Therap
- Cedax180MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 90MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · for suspension · Burke Therap
Italy
AIFA · 1 medicine
All medicines with Ceftibuten
Every register, a page at a time. Strengths and packs are on each medicine’s page.
5 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ceftibuten | Brazil | Cancelled | Laboratório Americano de Farmacoterapia S/A | ||
| Cedax | United States | 180MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 90MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | for suspension | Not marketed | Burke Therap |
| Cedax | United States | 400MG BASE | capsule | Not marketed | Burke Therap |
| Isocef | Italy | Granulato per sospensione orale | Authorised | Recordati Industria Chimica e Farmaceutica S.P.A. | |
| Ceften | Brazil | Cancelled | Laboratório Teuto Brasileiro S/A |